Primary Site >> Stomach Cancer
Gene >> IDO1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Immunoactivative role of indoleamine 2,3dioxygenase in gastric cancer cells in vitro. PMID: 21461581 |
Ref: Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PMID: 23671415 Ref: The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer. PMID: 23979437 |
Ref: The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment. PMID: 24870595 |
Ref: Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer. PMID: 27241062 Ref: Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer. PMID: 28201999 Ref: Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types. PMID: 29212506 |
Ref: Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity. PMID: 28912017 Ref: Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives. PMID: 29730461 Ref: The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer. PMID: 29848687 |